Ocean Biomedical Free Cash Flow Yield Over Time

OCEA Stock   0.68  0.05  7.94%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ocean Biomedical Performance and Ocean Biomedical Correlation.
For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.
  
As of January 13, 2025, Free Cash Flow Yield is expected to decline to -0.0024.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.00)
Return On Assets
(6.82)
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Free Cash Flow Yield Analysis

Compare Ocean Biomedical and related stocks such as Enveric Biosciences, Hepion Pharmaceuticals, and Elevation Oncology Free Cash Flow Yield Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldRoic
Payables TurnoverRoe
Return On Tangible AssetsEarnings Yield
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Capital Employed
Return On AssetsAsset Turnover
Return On Equity
2010201120122013201420152016201720182019202020212022202320242025
ENVB(2.0E-4)(0.01)(0.026)(0.0026)(0.0067)(0.0684)(0.0752)(0.0591)(0.6183)(0.2124)(0.1605)(0.561)(5.8952)(5.0234)(5.78)(5.49)
HEPA0.00.00.0(0.097)(0.0883)(0.5885)(0.5676)(0.2945)(4.3109)(0.6955)(0.7669)(0.3913)(1.5295)(3.1793)(3.66)(3.47)
ELEV(0.0201)(0.0201)(0.0201)(0.0201)(0.0201)(0.0201)(0.0201)(0.0201)(0.0201)(0.0201)(0.0455)(0.2159)(3.8712)(3.07)(3.53)(3.35)
ZURA(0.0088)(0.0088)(0.0088)(0.0088)(0.0088)(0.0088)(0.0088)(0.0088)(0.0088)(0.0088)(0.0088)(0.0088)(0.1047)(0.1603)(0.18)(0.19)

Ocean Biomedical and related stocks such as Enveric Biosciences, Hepion Pharmaceuticals, and Elevation Oncology Free Cash Flow Yield description

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

My Equities

My Current Equities and Potential Positions

Ocean Biomedical
OCEA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationNew York; U.S.A
ExchangeNASDAQ Exchange
null 0.68
When determining whether Ocean Biomedical is a strong investment it is important to analyze Ocean Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocean Biomedical's future performance. For an informed investment choice regarding Ocean Stock, refer to the following important reports:
Check out Ocean Biomedical Performance and Ocean Biomedical Correlation.
For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Ocean Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Ocean Biomedical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ocean Biomedical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...